Annual Working Capital
-$337.00 K
-$2.40 M-116.33%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual working capital is -$337.00 thousand, with the most recent change of -$2.40 million (-116.33%) on June 30, 2024.
- During the last 3 years, AYTU annual working capital has risen by +$3.87 million (+91.98%).
- AYTU annual working capital is now -100.72% below its all-time high of $46.66 million, reached on June 30, 2020.
Performance
AYTU Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$514.00 K
-$177.00 K-52.52%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly working capital is -$514.00 thousand, with the most recent change of -$177.00 thousand (-52.52%) on September 30, 2024.
- Over the past year, AYTU quarterly working capital has dropped by -$5.65 million (-110.01%).
- AYTU quarterly working capital is now -100.77% below its all-time high of $66.72 million, reached on December 31, 2020.
Performance
AYTU Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AYTU Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -116.3% | -110.0% |
| 3 y3 years | +92.0% | +94.3% |
| 5 y5 years | -103.3% | -103.2% |
AYTU Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -116.3% | +92.5% | -107.2% | +96.1% |
| 5 y | 5-year | -100.7% | +92.5% | -100.8% | +96.1% |
| alltime | all time | -100.7% | +92.5% | -100.8% | +96.1% |
Aytu BioPharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$514.00 K(+52.5%) |
| Jun 2024 | -$337.00 K(-116.3%) | -$337.00 K(-97.3%) |
| Mar 2024 | - | -$12.56 M(-274.8%) |
| Dec 2023 | - | $7.18 M(+39.9%) |
| Sep 2023 | - | $5.14 M(+148.8%) |
| Jun 2023 | $2.06 M(-145.7%) | $2.06 M(-129.7%) |
| Mar 2023 | - | -$6.95 M(-300.8%) |
| Dec 2022 | - | $3.46 M(+185.8%) |
| Sep 2022 | - | $1.21 M(-126.8%) |
| Jun 2022 | -$4.51 M(+7.4%) | -$4.51 M(+87.0%) |
| Mar 2022 | - | -$2.41 M(-81.5%) |
| Dec 2021 | - | -$13.03 M(+45.5%) |
| Sep 2021 | - | -$8.96 M(+113.1%) |
| Jun 2021 | -$4.20 M(-109.0%) | -$4.20 M(-125.7%) |
| Mar 2021 | - | $16.33 M(-75.5%) |
| Dec 2020 | - | $66.72 M(+51.8%) |
| Sep 2020 | - | $43.95 M(-5.8%) |
| Jun 2020 | $46.66 M(+363.8%) | $46.66 M(+13.2%) |
| Mar 2020 | - | $41.22 M(+1626.1%) |
| Dec 2019 | - | $2.39 M(-59.4%) |
| Sep 2019 | - | $5.88 M(-41.5%) |
| Jun 2019 | $10.06 M(+65.6%) | $10.06 M(-27.9%) |
| Mar 2019 | - | $13.96 M(-19.4%) |
| Dec 2018 | - | $17.32 M(+427.3%) |
| Sep 2018 | - | $3.28 M(-45.9%) |
| Jun 2018 | $6.08 M(-1144.1%) | $6.08 M(-40.7%) |
| Mar 2018 | - | $10.25 M(+248.3%) |
| Dec 2017 | - | $2.94 M(-52.8%) |
| Sep 2017 | - | $6.23 M(-1171.3%) |
| Jun 2017 | -$581.90 K(-3782.9%) | -$581.90 K(-153.7%) |
| Mar 2017 | - | $1.08 M(-8.6%) |
| Dec 2016 | - | $1.19 M(-150.1%) |
| Sep 2016 | - | -$2.37 M(<-9900.0%) |
| Jun 2016 | $15.80 K | $15.80 K(-99.8%) |
| Mar 2016 | - | $7.23 M(-27.4%) |
| Dec 2015 | - | $9.96 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $9.53 M(+45.2%) |
| Jun 2015 | $6.56 M(<-9900.0%) | $6.56 M(-186.9%) |
| Mar 2015 | - | -$7.55 M(>+9900.0%) |
| Feb 2015 | - | -$53.80 K(+17.2%) |
| Nov 2014 | - | -$45.90 K(-4.4%) |
| Aug 2014 | -$48.00 K(-98.3%) | -$48.00 K(+19.1%) |
| Jun 2014 | -$2.79 M(+2250.8%) | - |
| May 2014 | - | -$40.30 K(-73.7%) |
| Feb 2014 | - | -$153.20 K(+15.4%) |
| Nov 2013 | - | -$132.80 K(+11.9%) |
| Aug 2013 | -$118.70 K(+44.4%) | -$118.70 K(+3.5%) |
| May 2013 | - | -$114.70 K(+9.4%) |
| Feb 2013 | - | -$104.80 K(+12.2%) |
| Nov 2012 | - | -$93.40 K(+13.6%) |
| Aug 2012 | -$82.20 K(+51.7%) | -$82.20 K(+19.5%) |
| May 2012 | - | -$68.80 K(+6.3%) |
| Feb 2012 | - | -$64.70 K(+0.2%) |
| Nov 2011 | - | -$64.60 K(+19.2%) |
| Aug 2011 | -$54.20 K(-33.1%) | -$54.20 K(-6.9%) |
| May 2011 | - | -$58.20 K(+26.0%) |
| Feb 2011 | - | -$46.20 K(-49.4%) |
| Nov 2010 | - | -$91.30 K(+12.7%) |
| Aug 2010 | -$81.00 K(+94.7%) | -$81.00 K(+6.6%) |
| May 2010 | - | -$76.00 K(+13.6%) |
| Feb 2010 | - | -$66.90 K(+16.3%) |
| Nov 2009 | - | -$57.50 K(+38.2%) |
| Aug 2009 | -$41.60 K(+303.9%) | -$41.60 K(-1.7%) |
| May 2009 | - | -$42.30 K(+0.5%) |
| Feb 2009 | - | -$42.10 K(+32.8%) |
| Nov 2008 | - | -$31.70 K(+207.8%) |
| Aug 2008 | -$10.30 K(-41.1%) | -$10.30 K(+1960.0%) |
| May 2008 | - | -$500.00(-102.8%) |
| Feb 2008 | - | $18.00 K(-31.0%) |
| Nov 2007 | - | $26.10 K(-249.1%) |
| Aug 2007 | -$17.50 K | -$17.50 K(+96.6%) |
| May 2007 | - | -$8900.00 |
FAQ
- What is Aytu BioPharma annual working capital?
- What is the all time high annual working capital for Aytu BioPharma?
- What is Aytu BioPharma annual working capital year-on-year change?
- What is Aytu BioPharma quarterly working capital?
- What is the all time high quarterly working capital for Aytu BioPharma?
- What is Aytu BioPharma quarterly working capital year-on-year change?
What is Aytu BioPharma annual working capital?
The current annual working capital of AYTU is -$337.00 K
What is the all time high annual working capital for Aytu BioPharma?
Aytu BioPharma all-time high annual working capital is $46.66 M
What is Aytu BioPharma annual working capital year-on-year change?
Over the past year, AYTU annual working capital has changed by -$2.40 M (-116.33%)
What is Aytu BioPharma quarterly working capital?
The current quarterly working capital of AYTU is -$514.00 K
What is the all time high quarterly working capital for Aytu BioPharma?
Aytu BioPharma all-time high quarterly working capital is $66.72 M
What is Aytu BioPharma quarterly working capital year-on-year change?
Over the past year, AYTU quarterly working capital has changed by -$5.65 M (-110.01%)